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Abstract
Background: The asymptomatic phase of HIV-1 infection is characterized by a progressive depletion of uninfected
peripheral effector/memory CD4+ T cells that subsequently leads to immune dysfunction and AIDS symptoms. We
have previously demonstrated that the presence of specific gp120/V3 peptides during antigen presentation can
modify the activation of normal T-cells leading to altered immune function. The aim of the present study was to
map the specific transcriptional profile invoked by an HIV-1/V3 epitope in uninfected T cells during antigen
presentation.
Methods: We exposed primary human peripheral blood monocytes to V3 lipopeptides using a liposome delivery
system followed by a superantigen-mediated antigen presentation system. We then evaluated the changes in the
T-cell transcriptional profile using oligonucleotide microarrays and performed Ingenuity Pathway Analysis (IPA) and
DAVID analysis. The results were validated using realtime PCR, FACS, Western blotting and immunofluorescence.
Results: Our results revealed that the most highly modulated transcripts could almost entirely be categorized as
related to the cell cycle or transcriptional regulation. The most statistically significant enriched categories and
networks identified by IPA were associated with cell cycle, gene expression, immune response, infection
mechanisms, cellular growth, proliferation and antigen presentation. Canonical pathways involved in energy and
cell cycle regulation, and in the co-activation of T cells were also enriched.
Conclusions: Taken together, these results document a distinct transcriptional profile invoked by the HIV-1/V3
epitope. These data could be invaluable to determine the underlying mechanism by which HIV-1 epitopes interfere
with uninfected CD4+ T-cell function causing hyper proliferation and AICD.
Background
The asymptomatic phase of HIV-1 infection is charac-
terized by the progressive depletion of uninfected per-
ipheral effector/memory (CD45RO+) CD4+ T cells [1]
that leads to subsequent immunodeficiency and AIDS
symptoms. One of the potential implications of this dys-
function involves the mechanism of activation-induced
cell death (AICD) that becomes enhanced and acceler-
ated in uninfected CD45RO+/CD4+ T cells by the pre-
sence of the virus [2]. The interaction of the HIV viral
envelope glycoprotein, gp120, with CD4 on the host cell
surface induces conformational changes in the gp120
that allows the V3 domain of gp120 to interact with the
host cell chemokine receptors, CCR5 or CXCR4 [3,4].
Although the functional importance of V3 in HIV infec-
tion has been well established [5], the effects of V3 on
the host cell coreceptor signaling cascade have remained
e l u s i v et h r o u g ht h ep a s td e c a d e[ 6 , 7 ] .I nC C R 5 - t r o p i c
HIV isolates (R5 strains), participation of the gp120 V3
domain (V3 loop) in the interaction with CCR5 is cru-
cial for binding and cell entry [8-10]. R5 strains predo-
minate in the asymptomatic phase, whereas isolates that
utilize both CCR5 and CXCR4 (R5X4 strains) or only
CXCR4 emerge much later in 40-50% of infected
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to the clinical phase [11]. The persistence of an exclu-
sive R5 viral population in vivo is not rare and is suffi-
cient to cause immunodeficiency in the majority of
HIV-1 infected individuals who progress to AIDS
[12,13].
We have shown previously that antigen presentation
can be deregulated by the presence of V3 epitopes on
the surface of macrophages. CCR5 is one of the main
mediators of V3-induced intracellular signaling during
a n t i g e np r e s e n t a t i o nw h i c hl e a d st oA I C D ,t h eV 3 -
CCR5 interaction itself being of ionic nature [14,15].
Microarray studies utilizing the whole gp120 have
shown increased expression of genes belonging to mito-
gen-activated protein kinase signal transduction path-
ways and genes regulating cell cycle in PBMCs [13,16].
In view of the potential involvement of V3 in the
abnormal AICD process of uninfected CD4+ T cells, we
addressed in this study the effects of V3 on the intracel-
lular signaling of CD4+ T cells. We investigated the
transcriptional differences in primary human CD4+ T
cells attributed to the presence of V3 during antigen
presentation signaling. We exposed macrophages to lin-
ear synthetic lipopeptides from the crown of V3 pre-
sented on liposomes and then we induced antigen
presentation complex formation with CD4+ T cells via a
superantigen presentation system [17]. Implementing
oligonucleotide microarray mRNA analysis on CD4+ T
cells, we assessed the impact of the V3 crown on the
transcriptional state of the responding CD4+ T cells.
Functional classification of significantly modulated genes
and identification of canonical pathways and functional
gene networks analysis were performed by an Ingenuity
Pathways Analysis (IPA) platform and overrepresenta-
tion of functional ontologies by DAVID Bioinformatics
Resources [18,19].
Methods
Peptides and liposomes
The HIV-1 gp120/V3 peptide RKSIRIQRGPGRAFY
(LAI strain, a.a. 304-318) was synthesised using F-moc/
tBu chemistry (15). Lipopeptides were produced by
covalent binding of serine-S-[2,3-bis (palmitoyloxy)
-(2RS)-propyl]-n-palmitoyl- (R)cysteine (Boehringer
Mannheim Biochemica, Germany) to the V3 peptide,
according to the manufacturer’s instructions. Liposomes
were constructed by the dehydration-rehydration
method and were reconstituted with 100 μl distilled
water. Non-entrapped material was removed by washing
with PBS [15].
Cell isolation
Buffy coats from healthy, HIV-1/Hepatitis b sero-nega-
tive blood donors were obtained from Venizelio
Hospital Blood Transfusion Service, Heraklion, Crete.
Informed consent was obtained from all the participat-
ing volunteers. Peripheral blood mononuclear cells
(PBMC) were isolated by density gradient centrifugation
using ficoll-paque (Amersham-Pharmacia, Uppsala, Swe-
den) according to the manufacturer’si n s t r u c t i o n sa n d
cultured in RPMI-1640 medium supplemented with
antibiotics and 5% human serum. Depletion of CD8+
cells was carried out with the magnetic cell sorting
(MACS) system (Miltenyi Biotech, Germany) using PE
anti-human CD8 (Mouse IgG1, k, RPA-T8, BD Phar-
mingen) and anti-PE microbeads (Mouse IgG1, Miltenyi
Biotech, Germany), according to the manufacturer’s
instructions. After the completion of the cell culture
experiment, the cells harvested for the microarray analy-
sis consisted of 86% CD3+CD4+ and 11% CD3+CD8+
double positives. This cell population will be referred to
as “CD4-enriched”.
Cell culture and oligonucleotide microarray analysis
Primary cell cultures were cultivated in triplicate for 3
days with either plain liposomes (control) or liposomes
with lipoV3 peptides incorporated on the liposome sur-
face [15]. 8 hours after the addition of 1 ng/ml of sta-
phylococcal enterotoxin A [17] (Sigma-Aldrich
Chemical Co.), total RNA extraction was performed
according to the manufacturer’s instructions using
silica-based spin columns (Qiagen RNeasy kit, Hilden,
Germany). The RNA concentration was determined by
measuring the absorbance at 260 nm. The purity was
estimated by the 260/280 nm absorbance ratio and the
integrity was assessed by agarose gel electophoresis.
High quality RNA was obtained from three indepen-
dently treated cell cultures from the same donor. The
RNA samples were subjected to oligonucleotide micro-
arrays by Aros Applied Biotechnology (Denmark) using
the Human Genome U133 Plus 2.0 Array (Affymetrix,
Santa Clara, CA, USA) according to the manufacturer’s
instructions. These chips contained 54,000 probe sets
which could recognize transcripts from 38,500 human
genes. The V3 and control RNA samples were hybri-
dized onto three separate microarray chips each, and
the values were calculated using the student’st - t e s tt o
identify genes significantly modulated by V3 (p < 0.05,
fold change > 2.0). Significantly modulated genes were
defined as those with an absolute fold change of > 2.0
and a P value of < 0.05.
Gene expression data
The primary microarray gene expression data discussed
in this publication have been deposited in the ArrayEx-
press (European Bioinformatics Institute, EBI) database
through NCBI website under accession number E-
MEXP-1586, EBI http://www.ebi.ac.uk/microarray.
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We used two different bioinformatic tools to explore the
functional relationships among the genes identified: the
Ingenuity Pathway Analysis tool version 8.0 (IPA; Inge-
nuity
® Systems, Inc, Redwood City, CA http://www.
ingenuity.com and DAVID (Database for Annotation,
Visualization, and Integrated Discovery; http://david.
abcc.ncifcrf.gov/) as well as extensive examination of
published literature. IPA and DAVID provided comple-
mentary pathway analysis. IPA uses a proprietary knowl-
edge base while DAVID considers ontologies from the
Gene Ontology (GO) project and pathways from the
Kyoto Encyclopedia of Genes and Genomes (KEGG).
Functional classification of statistically significant gene
expression changes was performed with IPA. This soft-
ware analyzes RNA expression data in the context of
known biological response and regulatory networks as
well as other canonical pathways using as a reference
set the Ingenuity Pathways Knowledge Base (Genes
Only), filtering for molecules and relationships that are
associated with the immune system. For all analyses, the
right-tailed Fisher’s exact test was used to calculate a P-
value determining the probability that each biological
function assigned to that data set was due to chance
alone. Corrected p-values based on the Benjamini-Hoch-
berg method of accounting for multiple testing were
also calculated for significantly enriched Functions and
Canonical pathways. Networks of highly interconnected
genes were identified by statistical likelihood using the
following equation:
Score = −log10
⎛
⎝1 −
f−1  
i=0
C(G, i)C(N − G, s − i)
C(N, s)
⎞
⎠
Where N is the number of genes in the network of
which G are central node genes, for a pathway of s
genes of which f are central node genes. C(n, s) is the
binomial coefficient.
We also implemented DAVID gene functional classifi-
cation to obtain biologically enriched functional gene
groups with reference to our background list containing
54,000 probe sets, applying the criteria of high strin-
gency with kappa similarity threshold set to 0.40.
Cell cycle analysis
Progression through different cell cycle phases was
monitored by flow cytometric analysis of the DNA con-
tent of cell populations stained with propidium iodide
and was carried out with a fluorescence-activated cell
sorter. Briefly, 48 h after the addition of SEA, cells were
harvested, fixed in 70% cold ethanol for 2 hours at 4°C
and stained with 20 ug/ml propidium iodide solution
containing 100 ug/ml Rnase A at room temperature for
30 min. Flow cytometric analysis was performed on a
FACSCalibur (Becton Dickinson) using Modfit LT ana-
lysis software (Verity Software House, Inc., Topsham,
ME). A minimum of 20,000 cells was counted for each
sample.
Immunofluorescence
2*10
6 cells were prepared for staining using a Cytospin
centrifuge (Aero spray, Wescor, USA) for 5 min at 300
rpm. Attached cells were then fixed and permeabilized,
blocked in PBS containing 10% FBS, and stained with
MKi67 rabbit polyclonal antibody (Abcam, ab15580) at
a dilution 1:200 for 1 hour at room temperature. Cells
underwent secondary staining for 1 h with Alexa488-
conjugated rabbit antibody (Invitrogen, USA) at a dilu-
tion of 1:500. To-Pro 3 iodide (Invitrogen, USA) was
also used for the visualization of the nuclei. The samples
were observed under a confocal microscope (TCS SP2;
Leica).
Results
PBMCs were isolated from the buffy coats of volunteer
healthy blood donors [20] using ficoll-paque. CD8+ T
cells were negatively depleted yielding over 90% purity
of CD4+ T cells. The resultant cells were aliquoted for
triplicate stimulation experiments. The cells were
exposed for three days to liposome constructs for V3
lipopeptides to be incorporated into macrophage cell
membranes, followed by pulsing 1 ng/ml SEA [21].
Non-adherent CD4-enriched cells from each experiment
were harvested 8 hours after SEA treatment and were
pooled in equal proportions for RNA extraction. Tran-
scription profiles were generated (Aros Applied Biotech-
nology, Denmark) with Affymetrix U133 Plus 2.0 Array
chips. These chips contained 54,000 probe sets which
could recognize transcripts from 38,500 human genes.
The V3 and control RNA samples were hybridized onto
three separate microarray chips each, and the resultant
values were calculated using the student’s t-test to iden-
tify genes significantly modulated by V3 (fold change >
2.0, p < 0.05). The data from the microarray study were
deposited in the ArrayExpress (European Bioinformatics
Institute, EBI) database through the NCBI website
(accession number E-MEXP-1586, EBI). The objective of
our analysis was (a) to assess genes exhibiting an exten-
sive modulation, and (b) to identify the biological
themes and functional gene clusters as a coordinated
change among many gene products, while the effect of
each individual gene may be subtle.
The validity of microarray results was confirmed (a) by
quantitative real-time PCR (NOC2L, IFI6, NFAT5,
PI3KR1, CCNB1, TP53, MAP3K8, H-RAS); (b) by western
blotting (NFAT5, NOC2L); (c) by immunofluorescence
(NFAT5, MKi67); and (d) by FACS (NFAT5, CD38).
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with regulation of cell cycle and proliferation
Analysis of the microarray data revealed that 440 genes
were affected; 378 genes were up-regulated, 18 of which
for at least 10-fold, and 62 genes were down-modulated,
as compared to the control treatment. The top ranked
up- and down-regulated genes are presented in Table 1.
The most striking result was the 70-fold up-regulation
of NOC2L mRNA, a novel gene of the HDAC-indepen-
dent inhibitor for histone acetyltransferase (INHAT)
[22]. A 26-fold up-regulation of the mRNA level of
SEPT9 and SPIN encoding for septin 9 and spindlin 1
were also observed. NFAT5, a transcription factor that
facilitates cell proliferation under hypertonic conditions
was increased 18-fold due to V3 treatment. Finally, a
30-fold up-regulation of IFI6, an ISG with largely
unknown function, was observed, though this result did
not reach the statistical significance cut-off (p = 0.065).
Regarding down-regulated genes, the gene ATP-binding
cassette transporter G1 (ABCG1) that regulates choles-
terol homeostasis in peripheral CD4 T cells showed the
most significant down-regulation (-34.51 and -10.73
-fold). Other interesting genes that were down-regulated
included PRKAR1B (-5.61-fold), which encodes the reg-
ulatory subunit of cyclic AMP-dependent protein kinase
A (PKA), PPP2R1 (-2.89-fold), a constant regulatory
subunit of protein phosphatase 2 and ROCK1 (-2.56-
fold), a cAMP-dependent protein kinase/protein kinase
G/protein kinase involved in the regulation of Fas-
dependent induction [23]. As a general observation, the
most significantly up- and down-regulated transcripts
could almost entirely be categorized as related to the
cell cycle or transcriptional regulation.
Multiple biological processes are affected by V3 epitope
The assignment of genes to functional categories was
performed through the annotation of gene lists by IPA
and DAVID that classifies genes by their ontological
groups. Based on gene annotation from IPA, we classified
approximately 60% of all altered genes in 29 descriptive
categories of molecular and cellular functions, while 150
probe IDs (40,65%) remained uncategorized and 67
probe IDs (18,1%) did not correspond to genes (Figure 1,
Additional file 1). The category of “cell cycle” achieved
the highest degree of significance encompassing 52 genes
(2.65E-08-2.18E-02) of which 25 genes were involved in
mitosis (1.74E-04) and 5 genes in checkpoint control
(BUB1, BUB1B, CCNB1, CDC20, ZWINT) (1.27E-01).
The second most significant category comprised of 62
genes associated with gene expression (8.34E-06-1.94E-
02), of which 42 genes are implicated in DNA transcrip-
tion. Other significantly enriched categories represent
processes that serve the progression through cell cycle
and division, such as “DNA replication, recombination
and repair” (8.44E-06-2.18E-02) which included 27
genes associated with condensation of chromosomes,
quantity of mitotic spindle and the assembly of nucleo-
somes, “Cellular Assembly and Organization” which
included genes implicated in the missegregation of chro-
mosomes, quantity of mitotic spindle and bundling of
filaments, “Cellular Movement “(9.09E-05-2.06E-02) and
particularly cytokinesis which included 25 genes and the
category of “Cellular Compromise” (3.76E-04-1.94E-02)
consisting of 8 genes involved in disorganization of the
nucleolus and dissociation of the nuclear lamina.
Of note, a number of significantly enriched categories
included genes that orchestrate immune response to the
V3 epitope such as “ Cell-mediated immune response”
(25 genes) (1.24E-04-1.94E-02), “Infection Mechanism”
(34 genes) (5.82E-04-1.94E-02), “Antigen presentation”
(10 genes) (1.9E-03-2.06E-02), “humoral immune
response” (14 genes) (2.2E-03-2.18E-02), “immune cell
trafficking” (9 genes) (2.2E-03-2.06E-02), and “inflamma-
tory response” (10 genes) (2.2E-03-1.94E-02). Interest-
ingly, 28 genes significantly modulated by the V3
epitope were identified by IPA to participate in HIV-1
infection (4.25E-2), of which 5 were down-regulated
(Figure 2). 5 genes are involved in cell signaling
(CAMKK2, MED31, CHAF1, RREB1, PAK1, 3.79E
-3-
3.85E
-2), 5 genes in post-translational modification
(PDSS1, STT3A, CAMKK2, CHAF1A, MED31,5 . 2 7 E - 3 -
1.05E-2), 3 genes in the cell cycle (PAK1, CAMKK2,
BRBP) (9.2E-3- 4.9E-2) and 2 genes in lipid metabolism
(ARF1, IDH) (1.05E-2- 3.12E-2).
The categories of “Cellular Growth and Proliferation”
(1.11E-03-1.94E-02) and “Cell Death” (5.83E-04-2.11E-
02) were the most abundant comprising of 66 and 81
genes, respectively. Moreover, the significantly overre-
presented categories of “Cellular Development” (47
genes) (1,24E-04-2,18E-02) and “Cellular Function and
Maintenance” (32 genes) (1.24E-04-1.94E-02), included
mostly genes implicated in T cell development and
Table 1 Genes exhibited the highest modulation upon V3
treatment in a CD4+ T cell enriched population
Gene
Symbol
Fold
increase
p-value Gene
Symbol
Fold
decrease
p-value
NOC2L 69,98 0,040 ABCG1 -34,52 0,019
IFI6 30,44 0,065 ABCG1 -10,73 0,026
SEPT9 26,67 0,038 PGPEP1 -7,97 0,011
SPIN 26,02 0,018 PTPLA -7,36 0,050
HNRPM 18,48 0,004 PRKAR1B -5,61 0,034
NFAT5 17,99 0,051 FCN1 -4,89 0,010
NSUN6 17,19 0,027 SPATA21 -4,19 0,008
SRGAP2 16,22 0,006 FER1L3 -3,79 0,015
LOC440092 14,93 0,002 MYLIP -3,20 0,024
GAS7 14,77 0,008 S100A9 -3,12 0,047
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enriched categories included"RNA Post-Transcriptional
Modification” (11 genes) (4E-03-1.94E-02), “Protein
Degradation” (6 genes) (3.86E-03-3.86E-03) and “Protein
Synthesis” (8 genes) (3.86E-03-3.86E-03). Interestingly,
17 genes involved in lipid metabolism were modulated
by the V3 epitope, of which 6 genes participate in the
metabolism of cholesterol (ABCG1, DHCR24, HMGCR,
IL4, LDLR, SQLE)(Additional file 2).
Networks and canonical pathways influenced by the V3
epitope
IPA generated several well-defined unique networks,
consisting of 35 molecules each, out of the mapped
genes that were induced in the CD4-enriched popula-
tion by the V3 epitope. IPA ranks networks in order of
the consistency of the microarray results with relation-
ships confirmed by prior published results (Figure 3,
Additional file 3). The first network that achieved the
Cell cycle (62)
GAS7, CENPF, DLGAP5, LIF, VPRBP, HSPA1A, PIK3R1,
CUL4A, CSNK1A1, DICER1, MKI67, POLE, CHAF1A, PAK1,
ZWINT (includes EG:11130), NUCKS1, EPOR, KIF4A,
AURKA, TXNL4B, BUB1B, TPX2,R AD1, KAT2B, IRF7,
CCND2, ZFR, CD70, UHMK1, KIF11, UBE2C, ID2, CDC20,
SEPT9, BCL2, TOP2A, BRD4, CD38, CDCA5, NAMPT,
MARCKS (includes EG:4082), IL4, NUSAP1, CCNB1, CDK1,
BUB1, KIF15, SIRT2, CD80, SKIL, CAMKK2, CTNND1
Gene expression (65)
CENPF, KDM6B, ZNF281, LIF, ATXN1, CUL4A, ZBP1,
CBX3, ABCG1, CBX5, SET, ZNF350, CHAF1A, TCF25,
THRAP3, SOX4, EPOR, MED1, RAD1, KAT2B, IRF7,
TFAM, CNOT7, SYNJ2BP, MED31, DUSP4, SMURF2,
JAG1, AGRN, RBM39, UBE2I, RAP2A, ID2, RREB1,
TCF4, CHD4, IKZF1, DMD, EIF2S1, BCL2, GTF2A2,
NAA15, NFAT5, SENP3, TOP2A, RBM15, IL4, RSF1,
CCNB1, CSDA, TRIM66, ZNF224, CDK1, AIP, ZNF148,
ROCK1, NOC2L, SIRT2, THOC4, KLF5, UBN1, SP100,
SKIL,NRIP1, CAMKK2
DNA Replication, Recombination, Repair (27)
DLGAP5, ENTPD4, CDC20, VPRBP, HSPA1A, NCAPG
(includes EG:64151), TYMP, SET, CHAF1A, BCL2, POLE,
TOP2A, CDCA5, ZWINT (includes EG:11130), IL4, RSF1,
NUSAP1, CCNB1, MED1, KIF4A, AURKA, BUB1B, CDK1,
BUB1, TFAM, TMEM49, KIF11
Cellular Assembly -Organization ( 30)
LIF, RAB27B, PIK3R1, DMD, SEPT9, SET, CHAF1A, BCL2,
PAK1, WASL (includes EG:8976), LGALS8, NRD1, TOP2A,
BRD4, MARCKS (includes EG:4082), ZWINT (includes
EG:11130), RSF1, NUSAP1, CCNB1, KIF4A, AURKA, BUB1B,
CDK1, ROCK1, BUB1, ARF1, AGRN, JAG1, CXADR, KIF11
Hematopoiesis (25)
ID2, TCF4, HLA-DOA, LIF, CHD4, CUL4A, PIK3R1, PDPK1,
FBXW7, IKZF1, DICER1, BCL2, CD47, GIMAP5, WASL
(includes EG:8976), F5, TOP2A, CD38, RBM15, HBD,
CXCL11, IL4, SOX4, CCNB1, MLLT10, MED1, EPOR, CDK1,
IRF7,CD80, TLR5, CD70, BCL11A, JAG1
Immuneresponse (32)
CF4, HLA-DOA, ID2, LIF, CHD4, PIK3R1, FBXW7, PDPK1,
IKZF1, DICER1, BCL2, GIMAP5, CD47, WASL (includes
EG:8976), F5, TOP2A, IL4, SOX4, CCNB1, MLLT10, CDK1,
TLR5, CD80, CD70, BCL11A, PRKAR1B, CD38, RBM15,
AICDA, PTGDR, CXCL11, LDLR
Cellular Development, Cellular Function and 
Maintenance, Cellular Compromise, Cell Morphology (54)
CENPF, ID2, TCF4, HLA-DOA, LIF, CHD4, CUL4A, PIK3R1,
CSNK1A1, FBXW7, PDPK1, IKZF1, DICER1, BCL2, CD47,
PAK1, GIMAP5, WASL (includes EG:8976), LGALS8, F5,
TOP2A, CD38, NAMPT, RBM15, MARCKS (includes
EG:4082), IL4, CXCL11, SOX4, CCNB1, ATP1B1, MLLT10,
EPOR, MED1, CDK1, ROCK1, IRF7, CCND2, CD80, TLR5,
CD70, BCL11A, KLF5, HMGCR, JAG1, CXADR, UBE2I,
CTNND1, RAB27B, EIF2S1, CHAF1, RIF1, ARF1, GOPC, HBD
Infection Mechanism (34)
HLA-DOA, RREB1, SHCBP1, CAMK1D,V P R B P , RAB2A,
PPM1K, NGLY1, CHAF1A, IDH1, BCL2, ALKBH8, NECAB3,
PAK1, ARGLU1, DKFZP686O24166, SNRPA1, CXCL11,
TRIM66, MYOF, UNC93B1, INTS6, STT3A, ZNF148, PDSS1,
ARF1, LDLR, CD80, BCL11A, MED31, CXADR, CAMKK2,
ZNF785, UBE2C
Cell Death, Cellular Growth and Proliferation  (100)
CENPF, LIF, CAMK1D, QKI, HSPA1A, VPRBP, HMMR,
ATXN1, CUL4A, PIK3R1, CSNK1A1, DNAJC3, PDPK1,
FBXW7, ABCG1, TYMP, LYZ, DICER1, CBX5, PBK, SET, PAK1,
GIMAP5, LGALS8, TRAF4, SOX4, HSH2D (includes
EG:84941), G2E3, EPOR, MED1, RRM2, TXNL4B, AURKA,
BUB1B, BAG4, KAT2B, TFAM, RAPGEF2, CCND2, ZFR, CD70,
GCNT1, DUSP4, AGRN, JAG1, PPAT, UBE2C, TCF4, ID2,
CDC20, UGCG, EIF2S1, DMD, BCL2, CD47, BRD4, TOP2A,
CD38, NAMPT, IFI6, SERBP1, B4GALT5, IL4, API5, CCNB1,
CSDA, CDK1, ZNF148, ROCK1, BUB1, SIRT2, LDLR, CD80,
DHCR24, S100A9, KLF5, XAF1, DCLRE1B, SKIL, CHI3L1,
PPP2R1B, MKI67, GOLGA2, MYOF, TPX2, CNOT7, TES,
KIF11, YPEL3, IKZF, NFAT5, NRD1, PRKAR1B, RBM15, DTL,
UTP20, KIF15, NRIP1, HMGCR, HMGCR
Cellular Movement (25)
ID2, CDC20, PTGDR, CBX5, SEPT9, ZNF350, CD47, BRD4,
TOP2A, PRKAR1B, CD38, B4GALT5, CXCL11, IL4, NUSAP1,
CCNB1, KIF4A, AURKA, ROCK1, LDLR, CD80, SP100, CHI3L1,
SRRM1, CTNND1
Amino Acid Metabolism,  Lipid Metabolism (36)
LIF, CCNB1, PTPLA, PIK3R1, CSNK1A1, SLC7A1,
PPP1CB, PDPK1, AURKA, CDK1, BCL2, ROCK1,
KAT2B, PAK1, CD80, PXK, PRKAR1B, BRD4, DUSP4,
RSRC1, CAMKK2, IL4, SQLE, QKI, RAB27B, CPT1B,
UGCG, ABCG1, CD47, LDLR, DHCR24, LGALS8, FAR2,
PITPNC1, MARCKS (includes EG:4082), HMGCR
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Figure 1 Top molecular and cellular functions identified by IPA. (A) IPA categorized genes exhibited significantly altered expression
according to their molecular and cellular function. Green and red letters indicate decreased and increased expression, respectively. The number
in the parenthesis indicates the number of altered genes classified to a certain function. (B) The diagram shows significantly overrepresented
biofunctions. Corrected p-values, based on the Benjamini-Hochberg method of accounting for multiple testing, was applied by IPA to control
the error rate in analysis results. A corrected p-value (FDR) of < 0.05 was considered significant.
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Nucleus
Cytoplasm
Unknown
Figure 2 HIV-1 infection related genes modulated by V3 epitope during the process of antigen presentation. This diagram shows genes
associated with HIV-1 infection according to IPA Knowledge Base and their cellular location. Gene products are graphically displayed as nodes.
Nodes are further displayed using various shapes that represent the functional class of the gene product. The intensity of the node color
indicates the degree of up- (red) or down- (green) regulation.
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Page 6 of 16highest score (38), contained genes involved in gene
expression, cellular development and hematological sys-
tem development and function. Among these, LDLR,
HSPA1A, IKF1 and IDH2 are associated with immune
response and LYZ with HIV infection (Figure 3A). The
second network contained PP2A, PP1 protein complex
group, CDK1, CCNB1 and VEGF as main hubs connect-
ing cell cycle-promoting regulators, such as CDC20,
BUB1, MKI67 and AURKA (Figure 3B). The third net-
work consisted of a number of transcription regulators
and enzymes implicated in cellular growth and prolifera-
tion, and in the metabolism of lipids and nucleic acids.
NOC2L, the gene that exhibited the most significant up-
r e g u l a t i o nw a si n c l u d e di nt h i sn e t w o r k ,a sw e l la s
KAT2B, UBE2I and MED31 (Figure 3C). Interestingly,
the IFNa and NFB complex were the central hubs in
the fourth network, connecting genes related to antimi-
crobial response, inflammation and the immune
response, most notably, IFI6, IRF7, AICDA, CXCL11 and
the down-regulated TLR5 (Figure 3D)
Within IPA 23 statistically significant canonical path-
ways were enriched in the gene list when the corrected
Fischer’s exact test p-value (FDR) of < 0.05 was consid-
ered significant (Figure 4A, Additional file 4). The most
significant canonical pathway identified was AMPK Sig-
naling (FDR = 7.76E-4), the key pathway in energy regu-
lation in which PIK3R1, AK2, PDPK1, HMGCR, KAT2B,
CPT1B and PPAT were up-regulated, while PRKAR1B
and PPP2R1B were down-regulated. Other significant
overrepresented canonical pathways were involved in
cell cycle progression and cell proliferation. The “Breast
Cancer Regulation by Stathmin1” IPA-pathway (2.63E-3)
which includes the V3-modulated genes ROCK1, PAK1,
PPP1R10, CAMK1D, PIK3R1, PRKAR1B, PPP1CB,
UHMK1, PPP2R1B and CDK1, plays a regulatory role in
microtubule dynamics. In the “Mitotic Roles of Polo-
Like Kinase” IPA-pathway (5.24E-3), that regulates the
entry and exit in mitosis as well as cytokinesis, CCNB1,
KIF11 CDC20, CDK1 and PPP2R1B transcripts exhib-
ited an altered expression and in “Cell Cycle: G2/M
DNA Damage Checkpoint Regulation” IPA-pathway
(5.49E-3), CCNB1, TOP2A, CDK1 and KAT2B were up-
regulated. The “EIF2” IPA-pathway (6.76E-3), in which
the differentially expressed transcripts EIF3B, PIK3R1,
EIF4A1, PDPK1, PPP1CB and EIF2S1 participate, regu-
lates protein synthesis in response to various types of
environmental stress and plays a crucial role in the con-
trol of the cell cycle mediating both cell proliferation
and p53-dependent/independent apoptosis. Interestingly,
the “CD28 Signaling in T Helper Cells” IPA-pathway,
the most prominent costimulatory pathway of TCR sig-
naling, was also significantly enriched (7.41E-3), and key
molecules that participate in the pathway showed a sig-
nificant transcriptional up-regulation of over 4-fold
(Figure 4B). Other significantly enriched canonical path-
ways identified by IPA included the “Biosynthesis of
Steroids” (2.39E-2), “Integrin Signaling” (2.88E-2), “p53
Signaling” (2.95E-2), “Role of Pattern Recognition
Receptors in Recognition of Bacteria and Viruses”
(4.89E-2) and the “ERK/MAPK Signaling” (4.89E-2)
pathways.
We extended the analysis applying the DAVID Gene
Functional Classification Tool, a module-centric method
that takes into account the redundant and network nat-
ure of biological annotation contents in order to con-
centrate on the larger biological picture expressed in
biological modules rather than on individual genes.
Under high stringency, DAVID clustered these genes
into 10 functional groups depicted in Table 2. Promi-
nent within the list of gene clusters was the cluster of 5
molecules of the nuclear lumen and specifically of the
nucleolus. The second cluster contained 7 genes impli-
cated in nuclear division and in particular sister chro-
matide segregation. mRNA processing was the common
function of the 12 genes in the third cluster. 5 genes
involved in nuclear division were also annotated as
ATP-binding phosphoproteins, and included PBK,
KIF11 and AURKA, constituting the fourth cluster. The
fifth cluster contained 8 genes with helicase activity.
Intriguingly, 16 ATP-binding serine/threonine kinases
that regulate the cell-cycle process constituted the sixth
cluster. Other clusters included classified genes related
to negative regulation, zinc finger, cytoskeleton and WD
repeat.
The cell cycle state is influenced by the V3 epitope
The “Cell cycle” was the most highly enriched category
according our bioinformatic analysis. We validated these
results with 3 independent approaches:
(a) we characterised the cell cycle state of cell popula-
tions by FACS using 3 independent donors. We
observed a V3-dependent increase of cells in the S and
G2/M phases in all three donors. In donor 1, we
obtained a 4.1-fold increase in the percentage of cells
entering the S phase and 2.01-fold increase entering the
G2/M phase. The corresponding fold increases in
donors 2 and 3 were 1.6 and 1.2 for the S phase, and
2.46 and 3.26 for the G2/M phase, respectively;
(b) we analysed the mRNA kinetics of CCNB1 by
quantitative real-time PCR in 3 new donors. We
observed a significant V3-dependent fold-increase which
is indicative of the anticipated changes in the progres-
sion of cell cycle (additional file 5_CCNB1mRNA_ki-
netics) (c) finally, we investigated the number of MKi67
positive cells by immunofluorescence microscopy which
is indicative of their proliferation state. We observed a
distinct increase that further supports the impact of V3
on the cell cycle state (Figure 5).
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Figure 3 Top ranked networks identified by IPA. IPA networks that depict associations between genes involved in certain biological
functions: (a) Gene Expression, Cellular Development, Hematological System Development and Function (score 38), (b) Cell Cycle, Cancer,
Genetic Disorder (score 36), (c) Cellular Growth and Proliferation, Lipid Metabolism, Nucleic Acid Metabolism (score 35), (d) Genetic Disorder,
Metabolic Disease, Antimicrobial Response (score 32). The network is graphically displayed with genes/gene products as nodes (different shapes
that represent the functional class of the gene product, Figure 2) and the biological relationships between the nodes as edges (lines). The
diagrams show direct (solid lines) and indirect (dashed lines) interactions between genes known to orchestrate common functions. The length
of an edge reflects the evidence in the literature supporting that node-to-node relationship. Red and green shading denotes genes increased
and decreased in expression, respectively, and the intensity of the colour indicates the degree of modulation. Molecules overlaid with orange
and purple line are associated with immune response and HIV-1 infection, respectively. The score is derived from a p value and indicates the
likelihood of the focus genes in a network to be found together due to random chance.
Morou et al. Journal of Translational Medicine 2011, 9:160
http://www.translational-medicine.com/content/9/1/160
Page 8 of 16A.
B.
0
0.05
0.1
0.15
0.2
0.25
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
-
l
o
g
(
B
-
H
 
p
-
v
a
l
u
e
) -log(B-H p-value)
Ratio
Figure 4 Significantly enriched canonical pathways identified by IPA. (A) The diagram shows significantly overrepresented canonical
pathways. A multiple-testing corrected p-value was calculated using the Benjamini-Hochberg method to control the rate of false discoveries in
statistical hypothesis testing. The ratio value represents the number of molecules in a given pathway that meet cut criteria, divided by the total
number of molecules that belong to the function. (B) Illustration of altered genes involved in IPA canonical pathway “CD28 signaling in T helper
cells”. Ingenuity Pathways Analysis software was used to identify altered genes related to canonical apoptotic pathways; red and green colour
indicates genes significantly increased and decreased in expression, respectively. Black indicates no significant change in gene expression.
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The mechanism by which the uninfected CD4+ T cell
population is inexorably depleted during the asympto-
matic phase of HIV-1 infection remains elusive. From in
vitro functional studies using synthetic peptides, we
have concluded that the crown of the gp120 V3 loop
participates in the process of antigen presentation
between an HIV-infected macrophage and a responding
CD4+ T cell, driving the T cell to an accelerated and
enhanced AICD [17]. In the present study, we moni-
tored changes in the transcriptional profile generated by
specific signaling that is associated with the V3 epitope,
in a primary CD4+ enriched population using oligonu-
cleotide microarrays. Our results provided evidence that
the V3 epitope on the surface of macrophages exerts
differential and profound effects on cell cycle, gene
expression, energy and metabolic demands, orchestrat-
ing the proliferation and immune response of the
responding CD4+ T cells during antigen presentation.
Microarray technology and the synchronous develop-
ment of bioinformatics tools that enable a more integrative
and function-orientated analysis have shed some light on
the immunological imprint of HIV-1 and HIV-1 accessory
proteins on a variety of immune cell types [24]. Most of
the studies on the putative HIV-1-induced modulation of
host gene expression have been mostly performed in
established human cell lines that harbor defects in crucial
cellular functions, such as cell cycle, proliferation and
apoptosis. This is the first study, to our knowledge, that
explored the impact of a defined 15-amino acid V3 epitope
of the gp120 on the transcriptional processes of physiolo-
gical primary human CD4+ enriched cells. A negative
selection procedure was preferred to avoid any putative
antibody-mediated signaling events. Moreover, the Affy-
metrix chip used included genes from the whole genome
and not only genes related to immune response, thus pro-
viding an integral icon of V3 impact on responding T
cells. The validity of microarray results was confirmed on
a set of genes from three independent donors by real-time
reverse transcription polymerase chain reaction quantita-
tive real-time PCR (qRT-PCR).
To decipher the cellular processes most affected by
the V3 epitope, we classified genes with modulated tran-
scriptional expression into (a) functional categories
through IPA, and (b) into enriched gene modules
descriptive of biological processes, molecular functions
and cellular compartments by DAVID. Moreover, the
data set was mined for networks of interconnected
modulated genes, and for overrepresented pathways
within the IPA library of canonical pathways.
We focused our analysis on the identification of biolo-
gical themes and functional gene clusters, as a coordi-
nated change among many gene products may produce
potent biological effects, while the effect of each indivi-
dual gene could be less obvious. Nevertheless, we did
not underrate the role of each individual gene exhibiting
an extensive modulation, as interpreting the pathways
and functions of a set of differentially-expressed genes
Table 2 Ontological clustering of genes exhibiting altered expression according to DAVID
Cluster Enrichment
score
No of
genes
Annotated genes Gene ontology
1 7,52 5 KRR1, NOC2L, INTS6,UTP20,YPEL3 nuclear lumen, nucleolus
2 5,02 7 DLG7, NUSAP1, ZWINT, TPX2, HCAP-G, CEP164, CDCA5 nuclear division,
M phase of mitotic cell cycle sister chromatid segregation
nucleus
3 4,99 12 CUGBP2, SRP46, RNPC2, HNRPL, THOC4, SNRPA1,
PRPF40A, HNRPM, RSRC1, SRRM1, TRA2A, U2AF1
mRNA processing, mRNA metabolic process
4 4,37 5 PBK, KIF11, AURKA, KIF15, TPX2 nuclear division, M phase of mitotic cell cycle, ATP binding,
phosphoprotein
5 3,68 8 CHD9, ASCC3L1, DDX51, PXK, EIF4A1, MCM4, LGP2,
DDX24
helicase activity, nucleotide phosphate-binding region:ATP
6 3,37 16 CDC2, UHMK1, PBK, CSNK1A1, RIPK5, BUB1B, AURKA,
CAMKK2, BUB1, PMSF1, MAP3K1, PSMD7, CCNB1,
UBE2C, CAMK1D, CDC20
protein serine/threonine kinase activity cell cycle process, atp-
binding
7 2,89 5 ZNF148, TCF25, TCF4, CSDA, ZNF281 negative regulation of transcription from RNA polymerase II
promoter, negative regulation of RNA metabolic process
negative regulation of cellular biosynthetic process,
transcription factor activity nucleus, phosphoprotein
8 2,41 9 C13orf10, ZMYM4, ZC3H12C, ZCCHC2, SMYD4,
RFWD3, BIRC4BP, ZC3H11A, KIAA0182
zinc-finger transition metal ion binding
9 1,94 7 CHD9, ASCC3L1, DDX51, PXK, EIF4A1, MCM4, LGP2,
DDX24
cytoskeleton ATP binding intracellular non-membrane-
bounded organelle
10 1,92 5 WDR61, SLC25A32, TP53, FBXW7, DTL wd repeat
Group enrichment score ranks the biological significance of gene groups based on overall EASE scores of all enriched annotation terms.
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known mechanisms. Often these well-annotated genes
represent a minority of genes identified. As half of the
genome is poorly annotated [25], the truly new knowl-
edge arising from microarray experiments resides in the
functions of the poorly annotated genes.
Cell cycle control was the most overrepresented
biological function among classifications of genes
affected by V3
The nucleolus, which is mainly associated with ribosome
biogenesis, was the most highly overrepresented gene
module that emerged from DAVID analysis. An emerging
body of evidence indicates that the nucleolus is a dynamic
structure involved in the response to cellular stress
[26,27], in regulation of cell cycle and cell growth [28] and
can also be a target for virus infection [29]. Intriguingly,
NOC2L, the most significantly mRNA up-regulated gene
due to V3 treatment, is located in the nucleolus. NOC2L
transcribes an inhibitor of histone acetyltransferase with a
poorly defined role. Evidence suggests that NOC2L
directly interacts with p53 tumor suppressor inhibiting
p53-activated gene expression and p53- dependent apop-
tosis [22]. NOC2L also regulates transcription of CDKN1A
[30], PMAIP1 [31] and of TP53I3 [32], affecting cell cycle
progression and cell survival.
Prominent within the classifications were groups of
genes associated with the cell cycle. Cell cycle was not
only the most significantly enriched functional category,
but also was the theme of the second highest network.
Mki67 Topro-3
V3
Control
Figure 5 Immunofluorescent staining of the MKi67 antigen. Cells were exposed to V3-coated or control liposomes before activation with
SEA for 24 hr (green: Alexa-488 anti-MKi67 rabbit conjugate, blue: To-Pro 3 iodide nuclear staining).
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M phase of the mitotic cell cycle and specifically sister
chromatide segregation and ATP binding phosphopro-
teins as to play crucial role on cell cycle perturbation by
the V3 epitope. Canonical pathway analysis highlighted
the intracellular cascades that impair cell cycle progres-
sion focusing on the regulatory role of stathmin1
(STMN1) in microtubule dynamics, on the mitotic role
of Polo-like kinases, and on G2/M DNA damage check-
point regulation, the second checkpoint enforced during
the cell cycle. STMN1 is required for orderly progres-
sion through mitosis and is overexpressed across a
broad range of human malignancies. Polo-like kinases
are required at several key points through mitosis, start-
ing from control of the G2/M transition through phos-
phorylation of CDC25C and mitotic cyclins and in the
DNA damage checkpoint adaptation. Noteworthy, aber-
rant activation patterns of the Polo-like kinase pathway
were observed in the CD4+ T cells from SIV-infected
Rhesus Macaques (RM) following T-cell receptor stimu-
lation [33]. These results imply that the V3 epitope
infers cell cycle progression propelling cell division in
responding CD4 T cells, a process that requires pro-
found changes in the microtubule network that culmi-
nates in the formation of the spindle apparatus and the
vigilance of DNA integrity/content by regulators of G2/
M DNA damage checkpoint. The transcription of genes
encoding cyclins, cyclin-dependent kinases and cell cycle
regulators (cyclin I, cyclin D2, MKI67, CDC2, CCNB1)
and the E2F cycle-specific transcription factors (EIF2S1,
EIF3S9, EIF4A1) was enhanced presumably in order to
control tightly the above-mentioned processes. This is
consistent with earlier studies demonstrating that HIV-1
envelope glycoproteins expressed on T cells provoke
aberrancies in cell cycle regulatory proteins, specifically
accumulation of CCNB1 and hyperphosphorylation of
p34cdc2 (CDK1) kinase elicited by cell-cell contact with
T cells expressing CD4 coreceptors [34].
In chronically infected HIV-patients with active viral
replication, cell cycle dysregulation (CCD) is associated
with increased T-cell susceptibility to apoptosis and
involves increased activation of the G2/M phase-asso-
ciated CCNB/p34-cdc2 complex and abnormal nucleolar
structure with dysregulation of nucleolin turnover
[35,36]. Unscheduled p34-cdc2 activation may induce
cell death by a mechanism called mitotic catastrophe
[37] and CCD is consistently associated with increased
levels of activation-induced apoptosis [38]. Moreover, a
significantly larger fraction of CD4+ CD25+ T cells
from untreated HIV+ individuals expressed cyclin A
and/or cyclin B1 than was the case with those from
HIV- individuals [39].
In the most significantly enriched functional categories
and networks in our study, were genes associated with
gene expression, DNA replication recombination and
repair, and cellular development. They indicate that the
V3 epitope-CCR5 interaction alters the gene activity
facilitating T cell differentiation towards an immune
response state. Summarizing, our data suggest that V3
signaling incites CCD in responding CD4+ T cells. This
is consistent with our previous findings that the V3 epi-
tope condemns unifected CD4+ T cells to AICD, as
CCD has been associated with increased levels of AICD,
and there have been observations that this V3 epitope
increases the intracellular Ca
++ levels in responding
CD4+ T cells during antigen presentation [17].
Metabolic pathways affected by V3
The enhanced and accelerated proliferation induced by
V3 presumably demands of the T cell increased energy
to cope with the required amino acid and lipid metabo-
lism. The AMP-activated protein kinase (AMPK), the
most significant enriched pathway in our analysis, is a
key regulator of cellular energy homeostasis and was
recently shown to be activated by TCR-dependent Ca
++
signals [40]. Of special interest was also the up-regula-
tion of genes involved in the synthesis of cholesterol,
the basic component of lipid rafts. These highly ordered
plasma membrane microdomains are reported to play a
key organizing role in the formation of immunological
synapses, in TCR activation and HIV infection [41]. The
ATP-binding cassette transporter G1 (ABCG), a lipid
transporter that promotes cholesterol efflux and regu-
lates its subcellular distribution, was the gene that
exhibited the most significant down-regulation in
response to V3. Armstrong et al., in a recent study,
showed that the absence of ABCG1 in CD4
+ T cells
resulted in hyperproliferation in vitro, when cells are sti-
mulated via the TCR [42].
Genes associated with immune responses and antigen
presentation were significantly affected by the V3
epitope
The presence of V3 induced increased transcription of
genes that orchestrate immune response in responding
CD4+ T cells, with type I interferons and NFkB being
the key genes according to the IPA network. IFN-a is
produced by plasmacytoid dendritic cells (pDCs) and
elicits an antiviral program protecting CD4+ T cell
population against HIV-1. IFN-a inhibits HIV-1 replica-
tion, formation of infectious viral particles and induces
apoptosis of infected CD4
+ T cells. Thus, it may also
account for the depletory effect of HIV on uninfected
CD4+ T cells. It has been shown that when pDC and
CD4+ T cells bind non-infectious HIV-1, uninfected
pDC will produce IFN-a and CD4+ T cells will express
TRAIL and DR5, resulting in the preferential apoptosis
of uninfected T helper cells [43]. The protective/
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of immunopathogenesis, due to the fact that non-infec-
tious HIV-1 particles have been estimated to outnumber
infectious particles.
It is worth noting that a panel of interferon-stimulated
genes (ISGs) were up-regulated by the V3 epitope,
namely IFI6, IRF7, SP100 and IFRD1.T h ei n t e g r a lr o l e
of these ISGs in HIV pathogenesis is underpinned by
studies that corroborate the observed transcriptional up-
regulation in activated CD4+ T cells of untreated HIV-
positive individuals (IFI6, IRF7) [39], in an HIV-infected
CD4+ T cell population derived from human tonsils
(IFI6, IRF7, SP100) [44] and in lymphatic tissue of HIV-
1 positive individuals throughout all stages of infection
(IFI6) [45]. In addition, IFNa levels and ISG expression
are increased in progressor as compared with non-pro-
gressor HIV-infected individuals [46,47]. The highly up-
regulated transcriptional expression of ISGs in both
AGMs, SMs and RMs during acute SIV infection per-
sists only in pathogenic RMs during the chronic phase
of the infection while it is down-regulated to baseline in
AGMs and SMs [48,49]
Although NFB did not display any significant tran-
scriptional change, IPA network analysis attached
importance to the role of NF-Β in regulating immune
response. Transcriptional regulation by NF-Bi sc r u c i a l
in determining T cell fate and it has been implicated in
the onset of AICD [50]. Interestingly, it has been shown
that NF-B activity is considerably enhanced after bind-
ing of NF-B- N F A T 5c o m p l e x e st oBe l e m e n t so f
NF-B -responsive genes [51].
In our proposed model [52], the V3 loop subverts the
process of antigen presentation in order to facilitate HIV-
1 entry in CD4+ T cells. “CD28 signaling in T cells”,t h e
major driver of positive immune response that elicits sus-
tained IL-2 secretion, T cell division, clonal expansion
and differentiation was conspicuous among the enriched
canonical pathways. The pleiotropic impact of V3 on the
CD28 signaling pathway involved the remarkable up-reg-
ulation of the transcription factor, NFAT5, the amplifica-
tion of key genes acting in the PI3K/AKT cascade, as well
as the up-regulation of three molecules that participate
in CD3/CD28-triggered actin polymerization. NFAT5 is
a member of the Rel family of transcription factors,
which comprises of the NF-kB and NFAT proteins,
which are major regulators ofi m m u n er e s p o n s e[ 5 3 ] .I t
has been postulated that expression of NFAT5 is corre-
lated with the duration of antigen presentation. Pro-
longed TCR-dependent stimulation leads to sustained
activation of calcineurin and subsequent expression of
NFAT5. It has also been suggested that NFAT5 partici-
pates in specific aspects of host defense by up-regulating
TNF family genes that are culpable of AICD and other
target genes in T cells [54]. Such mechanisms, along with
the observed increased expression of NFAT5 by the V3,
support our hypothesis that the interaction of V3 with
the CCR5 receptor, during antigen presentation, results
in persistent activation of the responding CD4 T cells
leading subsequently to AICD [17].
V3 treatment also triggered the significant transcrip-
tional up-regulation of two key genes in the PI3K/AKT
cascade, PI3KR1 and PDPK1, that have been shown to
play a role in IL-2 induced T cell proliferation. A variety of
HIV proteins (gp120, gp160, Tat, Nef) impinge on pleio-
tropic PI3 pathway in order to facilitate HIV infection.
The observed up-regulation of mRNA levels of PI3KR1 is
reconciled with reports that associate gp120 of HIV-1 with
elevated PI3-kinase activity and calcium mobilization
through the chemokine receptors, CCR5 and CXCR4, in
primary CD4 lymphocytes andP I - 3 K -m e d i a t e dT N F - a
production in macrophages. These studies showed that
inhibition of the PI3-kinase signaling pathway suppresses
virus infection post-viral entry and post-reverse transcrip-
tion but prior to HIV gene expression [55,56].
The V3 epitope appeared to interfere with the CD28
signaling pathway by up-regulating N-WASP, PAK1 and
ARP2/3, the central genes of the host cell actin remodel-
ing machinery. Profound actin rearrangements at the
immunological synapse triggered by TCR/CR28 stimula-
tion lead to segregation of surface receptors and recep-
tor-proximal signaling machineries to modulate, amplify
and stabilize output signals to ensure ample T cell acti-
vation. It has been also proposed that gp120 modulates
the synapse triggering a rapid, actin-dependent recruit-
ment of CD4, CXCR4, and LFA-1 on the target cell dur-
ing cell-cell transmission between X4 HIV-1-infected
effector T cell and CD4+/CXCR4+ target T cell [57]. It
is interesting to note that that Nef impairs the ability of
infected lymphocytes to form immunological synapses
with antigen-presenting cells lowering TCR-mediated
stimulation [58]. Nef reduces actin polymerization inhi-
biting N-WASP that activates Arp2/3-mediated actin
nucleation in lymphocytes [59]. It is tempting to specu-
late that Nef manipulating the formation of immunolo-
gical synapses might counteract the activity of V3. To
ensure its transmission, the virus needs to establish a
balance between the apoptosis-prone activation state of
the recipient T cell and the replication unfavorable
environment of a resting T cell [60]. Thus, V3-CCR5
signaling acts as a double-edged sword; V3 renders cells
hyper-responsive to stimulation favoring HIV infection
and vigorous T cell proliferation, but in the case of an
abortive entry of HIV into a T cell, the cell undergoes
sustained proliferation but is condemned to AICD due
to the absence of Nef to balance the homeostatic
mechanisms of apoptosis.
Studies on the transcriptional imprint of gp120 have
been previously performed in astrocytes [61],
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MMDCs [64] and PBMCs [16]. In these studies, gp120
generated subtle changes in the transcriptional profile of
astrocytes and induced apoptotic genes of the Fas/FasL
pathway in keratinocytes. In NK cells, that lack CD4
receptor, gp120 signaling through CCR5 elicited up-reg-
ulation of genes involved in apoptosis and down-regula-
tion of genes involved in proliferation and survival. In
pDCs, gp120 interfered with the transcription of genes
associated with TLR9 activation and decreased the abil-
ity of pDCs to secrete antiviral and inflammatory fac-
tors, while in monocyte-macrophage dendritic cells, no
significant effect of gp120 on the transcriptional state
was found. The transcriptional changes by gp120 in
these type of cells were less profound than the modifica-
tions in T cells, which is consistent with the fact that
these type of cells are less conducive to HIV-1 infection.
In an elegant study by Cicala et al [16], in which the
effect of R5 and X4 gp120 on PBMCs was discriminated,
it was shown that R5 gp120s exerted a greater impact
on the transcriptional profile of responding cells than
X4 gp120, and the cell cycle and proliferation were
among the gene categories strongly modulated by V3.
Interestingly, treatment of cells from CCR5Δ32 homozy-
gous donors with gp120 derived from an R5 virus,
demonstrated that the majority of responses required
the engagement of the CCR5 coreceptor. Although in
t h ep r e s e n ts t u d yw ei n v e s t i g a t e dV 3 - s p e c i f i cs i g n a l si n
a CD4+ enriched population, our findings are consistent
with those reported by Cicala et al.
Conclusions
V3 re-immerged as a promising target for neutralizing
antibodies when the 3D structure was recently revealed.
However, its precise role in HIV infection remains elu-
sive. In this study, we showed that the crown of V3
imposes a strong transcriptional signature pattern on
responding CD4 T cells during antigen presentation
associated with cell cycle, gene expression, immune
response, infection mechanisms, cellular growth, prolif-
eration and antigen presentation Unveiling the key par-
ticipating molecules in intracellular signaling within the
responding CD4 T cells may provide the impetus to
design novel therapeutic strategies such as the salvaging
of uninfected T cells from HIV-induced AICD.
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